BREAKING: The FDA just reversed their 2023 peptide ban. 12 peptides pulled from the Category 2 restricted list: 1. BPC 157 2. Thymosin beta 4 fragment (TB 500) 3. Epitalon 4. GHK Cu 5. MOTS C 6. FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding. Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy